Open Access

[Retracted] miR‑154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor

  • Authors:
    • Xiaoli Pang
    • Kexin Huang
    • Qianqian Zhang
    • Yujiao Zhang
    • Junqi Niu
  • View Affiliations

  • Published online on: June 14, 2021     https://doi.org/10.3892/or.2021.8113
  • Article Number: 161
  • Copyright : © Pang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

August-2021
Volume 46 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Pang X, Huang K, Zhang Q, Zhang Y and Niu J: [Retracted] miR‑154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor. Oncol Rep 46: 161, 2021.
APA
Pang, X., Huang, K., Zhang, Q., Zhang, Y., & Niu, J. (2021). [Retracted] miR‑154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor. Oncology Reports, 46, 161. https://doi.org/10.3892/or.2021.8113
MLA
Pang, X., Huang, K., Zhang, Q., Zhang, Y., Niu, J."[Retracted] miR‑154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor". Oncology Reports 46.2 (2021): 161.
Chicago
Pang, X., Huang, K., Zhang, Q., Zhang, Y., Niu, J."[Retracted] miR‑154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor". Oncology Reports 46, no. 2 (2021): 161. https://doi.org/10.3892/or.2021.8113